Increased levels of inflammation and oxidative stress have also been reported in type 2 diabetic patients.205 Asemi et al.174 presented the first trial investigating the impact of a bacterial formulation on metabolic profiles, high-sensitivity- (hs-) CRP, and oxidative stress in type 2 diabetic patients. The gene discussed is CRP; the disease is type 2 diabetes mellitus.